Latest filing published 08 May 2015 for HYPERION THERAPEUTICS INC, €470k.
No signal scores available.
Christine A. Nash appears in our data through filings on Hyperion Therapeutics Inc shares, published by SEC (Form 4). The record holds 27 filings, for trades running from 31 July 2012 to 7 May 2015.
Every open-market trade on record is a sale: 11 sales worth €1.3M. Other entries cover 3 share grants and 9 option exercises. In 2015 alone, the filings show no purchases and 7 sales.
The newest entry dates from 8 May 2015: a transaction of €2.4M, in Hyperion Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations